U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893561) titled 'A Clinical Trial to Evaluate the Effects of Adrenal Adapt on Sleep Quality, Daytime Energy, Stress Resilience, and Cognitive Performance.' on Oct. 19.
Brief Summary: This is a single-group, open-label, uncontrolled clinical trial designed to evaluate the effects of Adrenal Adapt, a commercially available dietary supplement, on sleep quality, daytime energy, stress resilience, and cognitive performance over a 12-week intervention period in 40 healthy adults aged 18-60.
Study Start Date: Sept. 09
Study Type: INTERVENTIONAL
Condition:
Improves Daytime Energy Levels
Reduces Afternoon Energy Crashes and Midday Fatigue
Improves Overal...